根据先前的生物使用和关键的临床亚组,在严重的乙酸性喘中使用本拉利祖马布:现实世界XALOC-1计划
David J Jackson1,2, Girolamo Pelaia3, Benjamin Emmanuel4
1Guy's Severe Asthma Centre, Guy's and Thomas' NHS Trust, London, UK david.jackson@gstt.nhs.uk.
The European respiratory journal
|April 4, 2024
概括
贝纳利祖马布显著改善了严重酸性喘 (SEA) 患者的结局,减少了恶化和口服皮质类固醇的使用. 这些好处在各种患者群体中观察到,包括那些先前接受过生物治疗的患者.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重酸性喘 (SEA) 管理从现实世界的有效性数据中受益.
- 本拉利祖马布在关键试验和SEA实践研究中已经证明了它的有效性和安全性.
- 根据先前的生物使用和患者特征,需要更多关于本拉利祖马布有效性的数据.
研究的目的:
- 评估本拉利祖马布在SEA.成年人中的实际有效性.
- 根据先前的生物使用和关键基线特征来评估结果.
- 分析恶化率,口服皮质类固醇的使用,症状控制和肺功能.
主要方法:
- XALOC-1研究是一项大型,跨国,回顾性,实验性的观察性研究.
- 在本拉利祖马布治疗开始后48周内对1002名患者的综合分析.
- 亚组分析包括先前的生物使用和临床因素,如血中乙氨基酸细胞计数和OCS使用.
主要成果:
- 71.3%的患者在48周后没有恶化,AER的相对减少为82.7%.
- 47.4%接受维持性口服皮质类固醇 (mOCS) 治疗的患者在第48周内停止使用.
- 在亚组中观察到喘症状控制和肺功能显著改善.
结论:
- 在SEA患者中,本拉利祖马布治疗导致了实质性的临床结果改善.
- 无论之前的生物暴露或基线特征如何,有效性都是一致的.
- 现实世界的数据支持benralizumab在不同患者群体的SEA管理中的作用.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
288
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
288
01:19Antiasthma Drugs: Leukotriene Modifiers
291
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
291
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
261
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
261
01:17Drugs Used in Lower Respiratory Disorders: Overview
437
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
437
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:24Antiasthma Drugs: Methylxanthines
226
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
226